OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer

Most Oral Blood Cancer Prescriptions Face Insurance Rejection or Cost Barriers, US Study Finds

SLACOM Session at LGCW: Why Breast and Cervical Cancer Prevention Is Failing, and How to Fix It

Matthias Preusser: Can Re-Irradiation Improve Survival in Patients with Recurrent Glioblastoma?

DREAMM-3 Final Results: Belantamab Mafodotin Extends Response Duration Without a Survival Gain in RRMM

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Henry Fung: The Evolving Role of Elranatamab in Multiple Myeloma Treatment

Humaid Al-Shamsi: Burjeel Cancer Institute is The First Specialized Oncology Institute Worldwide to Achieve Three ESMO Designated Centre Recognitions

Radiotherapy

OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.